Drug Markets/Pentazocine hydrochloride and naloxone hydrochloride

Pentazocine hydrochloride and naloxone hydrochloride

2 NDCs across 2 manufacturers|2 Generic,0 Brand

Total NDCs

2

2G / 0B

Manufacturers

2

competing in market

Price Spread

$2.01 – $2.01

7d Activity

4↑-2 flat

of 2 total NDCs

Market Price Trend

Monthly average NADAC price per unit, split by generic and brand

Manufacturer Breakdown

2 manufacturers producing Pentazocine hydrochloride and naloxone hydrochloride

Actavis Pharma, Inc.

Lupin Pharmaceuticals Inc.

Drug Portfolio

2 NDCs total, 2 shown

Drug ↕	NDC	Manufacturer ↕	Price	Market Outlier	Class	7d Change ↕	Therapeutic Class
PENTAZOCINE-NALOXONE TABLET	00591039501	Actavis Pharma, Inc.	$2.0130 per EA	—	Generic	+0.86%	Opioid Antagonist, Partial Opioid Agonist/Antagonist
PENTAZOCINE-NALOXONE TABLET	43386068001	Lupin Pharmaceuticals Inc.	$2.0130 per EA	—	Generic	+0.86%	Opioid Antagonist, Partial Opioid Agonist/Antagonist

Pentazocine hydrochloride and naloxone hydrochloride - Drug Market | NADAC Intelligence